Ivy Rx review
A range, not a floor
Semaglutide runs $175 to $197 a month and tirzepatide $275 to $297 — both ends published, not just the low one.
Our verdict
Publishing the top of the range is unusual and quietly valuable. Most of this market advertises a floor and leaves you to discover the ceiling; Ivy Rx names a $22 spread on each molecule, so the worst case is knowable before an intake. The prices themselves are mid-field, and the $100 step between molecules is toward the wide end.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- compounded semaglutide
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Availability
- 50 states
- Updated
- September 2026
What it is
A fifty-state telehealth service prescribing compounded semaglutide and tirzepatide by weekly injection, with pricing quoted as a range.
How it works
Prescription-gated telehealth on a monthly rate, with the range published on the menu rather than resolved only at checkout.
Pricing transparency
Semaglutide $175 rising to $197; tirzepatide $275 rising to $297. A $22 spread on each, with both ends stated.
Branded vs compounded
Compounded semaglutide and tirzepatide. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing.
Pros and watch-outs
What we like
- Both ends of the range published, so the ceiling is knowable
- A $22 spread is narrow — the range is informative, not evasive
- Fifty states
- Prices stated before the intake
Watch-outs
- $175 is mid-field rather than cheap
- $100 step to tirzepatide is toward the wide end
- What moves a price within the range is not explained
- Injection only
Best for
Buyers who would rather see the ceiling than be told a floor.
Who should look elsewhere
Anyone shopping the lowest published figure.
How Ivy Rx compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Oak
Flat dose pricing without a subscription
See Oak → - Synergy Rx
Both molecules in both forms
See Synergy Rx → - Care Bare Rx
A single entry price, if you are starting on semaglutide
See Care Bare Rx →
More compounded semaglutide sellers reviews: Rylo HealthThe EditTMatesTrellis VitalityTrimi HealthTrimRx
Evidence & trials · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of Ivy Rx’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Why does Ivy Rx quote a range?
- It does not say what moves the price within it — dose, plan length and pharmacy are all possibilities. What matters for comparison is that the top is published at all: a seller quoting only $175 could land you anywhere, and here the worst case is $197.
- Which end of the range should I budget for?
- The top. A $22 spread is small enough that planning on $197 costs you little if you land lower, and it removes the surprise if you do not.
- How does Ivy Rx compare on price?
- Mid-field. $175 to $197 for compounded semaglutide sits around the middle of what this market publishes, and $275 to $297 for tirzepatide is above it.
- Is the price flat across doses?
- The published range is the same across the menu rather than rising per dose tier, so escalation is not the variable driving it.
- Is Ivy Rx legit?
- Ivy Rx is a compounded semaglutide sellers service. Its stated availability: 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Ivy Rx expensive compared with other compounded semaglutide sellers providers?
- Ivy Rx publishes a starting figure of $175/mo. Across the 59 compounded semaglutide sellers providers we review that publish a single monthly figure, those run $79 to $369 with a median of $150, which puts Ivy Rx above the median. The other 1 compounded semaglutide sellers providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.